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ml of pre-hydrogel solution (poly(ethylene glycol) dimethacrylate
(10% w/v), photoinitiator (0.05% w/w) (Irgacure 2959) in phosphate
buffered saline) was exposured to 365 nm light (2 mW/cm2)
for 10 min solidifying the solution and encapsulating the cells
in gels of 5mm diameter and height. Inorganic pyrophosphate
(PPi) was added to the culture medium at 1mM. Control gels
did not receive PPi. Hydrogel properties were characterized by
compressive modulus, equilibrium swelling ratio (mass swollen
gel/mass of dry gel), and mesh size in the presence and absence
of PPi. Cell-laden constructs were cultured for 48 hours. Cell
viability was assessed using the LIVE/DEAD membrane integrity
assay after 48 hours. Cell proliferation was assessed by [3H]-
thymidine incorporation and proteoglycan synthesis by 35SO4-
incorporation. An n=3 was used for each condition. A student’s
t-test was performed with a p-value<0.05 considered signiﬁcant.
Results: The presence of PPi did not affect the macroscopic
properties of the hydrogel (Table 1). From the equilibrium swelling
ratio, which is a measure of the amount of water the hydrogel
imbibes, the mesh size was determined to between 18-20 nm
indicating that PPi can readily diffuse through the hydrogel.
Table 1. Macroscopic Properties of PEG Hydrogels in the Presence of PPi
Compressive Modulus Equilibrium Swelling Mesh Size
(kPa) Ratio (nm)
Control 110±17 12±2.2 18±4.4
PPi 110±6.0 13±2.0 20±4.1
The effects of PPi on cell proliferation and matrix production is
given in Table 2. PPi had no signiﬁcant effect on cell proliferation.
However, PPi dramatically inhibited proteoglycan synthesis by
72%. There was a 2.7-fold increase in proteoglycan loss into
the culture medium in the presence of PPi, which suggests that
proteoglycans are being degraded and which is mediated by PPi.
Table 2. Chondrocyte Response to PPi
Control PPi
Cell Proliferation (cpm/construct) 710±140 530±100
Proteoglycan Synthesis (cpm/construct) 7300±130 *2000±240
Percent Proteoglycan Loss (%/construct) 18±11 *49±3.7
*Denotes statistical signiﬁcance from control
Conclusions: High levels of exogenously delivered PPi to
chondrocyte-laden hydrogels inhibited matrix synthesis and in-
creased matrix loss into the culture medium, but did not affect
cell proliferation. Our ﬁndings suggest a role for PPi in mediating
matrix synthesis and degradation. PPi (at micromolar concentra-
tions) and PPi-derived Pi (at millimolar concentrations) are known
to be signaling molecules, and our results indicate that the ele-
vated (micromolar) level of extracellular PPi in aging cartilage, by
itself exerts functionally signiﬁcant effects on chondrocyte matrix
homeostasis.
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Purpose: Many people present themselves with hip or knee pain
at the general practitioners ofﬁce each year. The cause of this
pain is often thought to be osteoarthritis (OA), but not all these
people have radiological signs of OA in the painful joint.
It is not yet possible to determine in an early stage of the disease
who will develop OA pathology in a later stage. In this study
we aim to identify what the determinants are for developing OA
pathology on x-ray at follow-up, in people with pain at baseline but
no radiological OA (ROA) at baseline (Kellgren & Lawrence score
(K&L) ≤2).
Methods: Data of participants of the Rotterdam study (a
population-based cohort study), aged ≥55 years, was assessed
on the presence of hip or knee pain. A total of 452 subjects
with hip pain at baseline (mean age 68.5, 72.1% females) and
546 subjects with knee pain at baseline (mean age 70.0, 66.5%
females) were included; all without ROA in the painful joint at
baseline. Univariate and multivariate analyses (inclusion based on
p< 0.1 in univariate analyses) were used to determine predictors
for ROA at follow-up (mean 6.6 years). Tested baseline variables
include: other joint complaints and medical consumption for these
complaints, patient characteristics (age, sexe, diabetes), OA re-
lated aspects (familial OA, herberdens’ nodes, OA in other joint
(hip or knee) than the joint with complaints, morning stiffness, and
lower limb disability) and for women only female-hormone related
aspects (hormone use, age ﬁrst/last menstruation and years since
menopause).
Results: Of the included subjects with hip or knee pain at baseline
resp. 12.6% and 7.1% developed ROA at follow-up. Best predictor
of hip ROA at follow-up in those with hip pain was ‘knee OA
at baseline’ (K&L ≥2) in multivariate analysis of all subjects
(OR =4.362, p=0.016) as well as in univariat alnalysis in women
only (OR=4.700, p=0.036). For the men ‘familial OA’ (OR=6.114,
p=0.021) was the only signiﬁcant determinant in univariat analysis.
For predictors of knee ROA at follow-up in those with knee pain the
multivariate analysis of all subjects resulted in a model including
the determinants BMI (OR=1.305, p=0.016) and treatment of
joint complaints in the 5 years preceding baseline (OR=0.103,
p=0.044). In women the same variables remained signiﬁcant in
multivariate analysis with outcomes resp. OR=1.185, p=0.026 and
OR=0.288, p=0.029. For the men no variable was signiﬁcant
(p<0.05) in univariat analysis. All outcomes are adjusted for age.
Conclusions: Determining who will develop ROA in a later stage,
in people with joint pain but no radiographic OA, may help to
discriminate between true OA diagnosis and other pathologies.
It will also make it possible to identify subjects eligible for early
prevention studies, and with this hopefully preventing deterioration
into a severe OA in the future.
In predicting development of hip ROA, having knee OA and familial
OA seem to be the most important determinants. For development
of knee ROA best predictors are a combination of high BMI
and having had treatment for joint complaints in the ﬁve years
preceding baseline.
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Purpose: Pain is the most common, disabling symptom for people
with Osteoarthritis (OA). Improved understanding of pain mecha-
nisms in OA, including the development of "clinically feasible" tools
to identify individuals with central sensitization causing neuropathic
pain (NP) is essential to the development of mechanism-based
pain therapies. In adults with chronic symptomatic knee OA, this
study assessed: 1. the proportion of participants with NP symp-
toms as measured by a NP questionnaire modiﬁed for use in OA,
the modiﬁed painDETECT (mPD-Q); 2. convergent construct valid-
ity of the mPD-Q by co-administration of another NP questionnaire,
the Self-completed Leeds Assessment of Neuropathic Symptoms
